Open AccessCardiac Catheterization in Children with Pulmonary Hypertensive Vascular Disease: Consensus Statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces
Author(s) -
Cerro Maria Jesus,
Moledina Shahin,
Haworth Sheila G.,
Ivy Dunbar,
Dabbagh Maha Al,
Banjar Hanaa,
Diaz Gabriel,
HeathFreudenthal Alexandria,
Galal Ahmed Nasser,
Humpl Tilman,
Kulkarni Snehal,
Lopes Antonio,
Mocumbi Ana Olga,
Puri G. D.,
Rossouw Beyra,
Harikrishnan S.,
Saxena Anita,
Udo Patience,
Caicedo Lina,
Tamimi Omar,
Adatia Ian
Publication year - 2016
Publication title -
pulmonary circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.791
H-Index - 40
ISSN - 2045-8940
DOI - 10.1086/685102
Subject(s) - medicine , cardiac catheterization , disease , heart disease , vascular resistance , intensive care medicine , pulmonary hypertension , cardiology , vascular disease , hemodynamics
Cardiac catheterization is important in the diagnosis and risk stratification of pulmonary hypertensive vascular disease (PHVD) in children. Acute vasoreactivity testing provides key information about management, prognosis, therapeutic strategies, and efficacy. Data obtained at cardiac catheterization continue to play an important role in determining the surgical options for children with congenital heart disease and clinical evidence of increased pulmonary vascular resistance. The Pediatric and Congenital Heart Disease Task Forces of the Pulmonary Vascular Research Institute met to develop a consensus statement regarding indications for, conduct of, acute vasoreactivity testing with, and pitfalls and risks of cardiac catheterization in children with PHVD. This document contains the essentials of those discussions to provide a rationale for the hemodynamic assessment by cardiac catheterization of children with PHVD.